Skip to main content

Advertisement

SpringerLink
Log in

The prevalence of ureaplasma urealyticum, mycoplasma hominis, chlamydia trachomatis and neisseria gonorrhoeae infections, and the rubella status of patients undergoing an initial infertility evaluation

  • Assisted Reproduction
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To determine the prevalence of positive test for Ureaplasma urealyticum (UU), Mycoplasma hominis (MH), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) infections, and their corresponding Rubella status when undergoing workup for infertility.

Methods

Retrospective chart review to determine infection status for UU, MH, CT, and NG as determined by cervical swab, as well as the serum Rubella antibody titer.

Results

A total of 46 patients of the patients reviewed were positive for UU (20.1%), three patients were positive for MH (1.3%), five patients were positive for CT (2.2%) and one patient was positive for NG (0.4%). Rubella immunity was confirmed in 90.3% of patients.

Conclusion

Approximately one quarter of women presenting to an infertility clinic seeking to conceive were found to have a positive test for UU, MH, CT or NG infection. Additionally, almost 10% of the patients were Rubella non-immune at the time of presentation for infertility evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Webster LA, Greenspan JR, Nakashima AK, Johnson RE. An evaluation of surveillance for Chlamydia trachomatis infections in the United States (1987–1991). MMWR CDC Surveill Summ 1993;42:21–7.

    PubMed  CAS  Google Scholar 

  2. Quinn TC, Zenilman J, Rompalo A. Sexually transmitted diseases: advances in diagnosis and treatment. Adv Intern Med 1994;39:149.

    PubMed  CAS  Google Scholar 

  3. Alexander LA, Cates JR, Herndon N, Ratcliff JM. Sexually transmitted diseases in America. Menlo Park, CA: Kaiser Family Foundation; 1998. December.

    Google Scholar 

  4. Miller WC, Ford CA, Morris M. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004;291:2229.

    Article  PubMed  CAS  Google Scholar 

  5. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993;168:1503–9.

    PubMed  CAS  Google Scholar 

  6. Cates W Jr, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991;164:1771.

    PubMed  Google Scholar 

  7. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 1995;22:71.

    Article  Google Scholar 

  8. Harger JH, Archer DF, Marchese SG, Muracca-Clemens M, Garver KL. Etiology of recurrent pregnancy losses and outcome of subsequent pregnancies. Obstet Gynecol 1983;62:574–81.

    PubMed  CAS  Google Scholar 

  9. Stray-Pedersen B, Eng J, Reikvam TM. Uterine T-mycoplasma colonization in reproductive failure. Am J Obstet Gynecol 1978;130:307–11.

    PubMed  CAS  Google Scholar 

  10. Taylor-Robinson D. Infections due to species of Mycoplasma and Ureaplasma: an update. Clin Infect Dis 1996;23:671–82.

    PubMed  CAS  Google Scholar 

  11. Mardh PA, Westrom L. Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasmas. Br J Vener Dis 1970;46:179.

    PubMed  CAS  Google Scholar 

  12. Thomsen AC, Lindskov HO. Diagnosis of Mycoplasma hominis pyelonephritis by demonstration of antibodies in urine. J Clin Microbiol 1979;9:681–7.

    PubMed  CAS  Google Scholar 

  13. Cassell GH, Davis RO, Waites KB, Brown MB, Marriott PA, Stagno S, Davis JK. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10:294–302.

    PubMed  CAS  Google Scholar 

  14. Witkin SS, Kligman I, Grifo JA, Rosenwaks Z. Ureaplasma urealyticum and Mycoplasma hominis detected by the polymerase chain reaction in the cervices of women undergoing in vitro fertilization: prevalence and consequences. J Assist Reprod Genet 1995;12:610–4.

    Article  PubMed  CAS  Google Scholar 

  15. Rodriguez R, Hernandez R, Fuster F, Torres A, Prieto P, Alberto J. Genital infection and infertility. Enferm Infec Microbiol Clin 2001;19:261–6.

    CAS  Google Scholar 

  16. Gump DW, Gibson M, Ashikaga T. Lack of association between genital mycoplasmas and infertility. N Engl J Med 1984;310:937–41.

    Article  PubMed  CAS  Google Scholar 

  17. Nagata Y, Iwasaka T, Wada T. Mycoplasma infection and infertility. Fertil Steril 1979;31:392–5.

    PubMed  CAS  Google Scholar 

  18. McCormack WM, Rosner B, Lee Y. Colonization with genital Mycoplasmas in women. Am J Epidemiol 1973;97:240.

    CAS  PubMed  Google Scholar 

  19. Taylor-Robinson D, McCormack WM. The genital mycoplasmas. N Engl J Med 1980;302:1003.

    Article  PubMed  CAS  Google Scholar 

  20. Lee YH, Rosner B, Alpert S, Fiumara NJ, McCormack WM. Clinical and microbiological investigation of men with urethritis. J Infect Dis 1978;138:798–803.

    PubMed  CAS  Google Scholar 

  21. Marais NF, Wessels PH, Smith MS, Gericke A, Richter A. Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum infection in Women. Prevalence, risk and management at a South African infertility clinic. J Reprod Med 1991;36:161–4.

    PubMed  CAS  Google Scholar 

  22. Best JM. Rubella Seminars in Fetal and Neonatal Medicine 2007;12:182–192

    Google Scholar 

  23. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001;50:1117.

Download references

Author information

Authors and Affiliations

  1. Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Wayne State University, 3750 Woodward Avenue, Suite 200-D, Detroit, MI, 48201, USA

    Anthony N. Imudia, Laura Detti, Elizabeth E. Puscheck, Frank D. Yelian & Michael P. Diamond

Authors
  1. Anthony N. Imudia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Detti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth E. Puscheck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frank D. Yelian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael P. Diamond
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. Diamond.

Additional information

Determination of ureaplasma, mycoplasma, chlamydia and gonorrheae infections as well as rubella status in patients undergoing infertility treatment is important during the initial evaluation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imudia, A.N., Detti, L., Puscheck, E.E. et al. The prevalence of ureaplasma urealyticum, mycoplasma hominis, chlamydia trachomatis and neisseria gonorrhoeae infections, and the rubella status of patients undergoing an initial infertility evaluation. J Assist Reprod Genet 25, 43–46 (2008). https://doi.org/10.1007/s10815-007-9192-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-007-9192-z

Keywords

Search

Navigation